Related Experiment Video
Updated: Aug 8, 2026

11:36
Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
22.5K
Case Report: Mucosal Leishmaniasis in New York City
Henry W Murray1, Daniel P Eiras1, Laura A Kirkman1
1Division of Infectious Diseases, Department of Medicine, Weill Cornell Medical College, New York, New York.
The American Journal of Tropical Medicine and Hygiene
|April 2, 2020
Summary
Two new cases of mucosal leishmaniasis (ML) were diagnosed in New York City. One case, caused by Old World Leishmania tropica, is the first reported in the US, while the other involved Leishmania (Viannia) braziliensis.
Area of Science:
- Infectious Diseases
- Parasitology
- Public Health
Background:
- Mucosal leishmaniasis (ML) is a neglected tropical disease caused by protozoan parasites of the genus Leishmania.
- Previous civilian cases of ML in the United States were exclusively imported New World leishmaniasis.
- Understanding the geographic distribution and species causing ML is crucial for diagnosis and treatment.
Observation:
- This report details two distinct cases of ML diagnosed in New York City.
- The first patient, a Syrian immigrant, presented with a nasal mass caused by Leishmania tropica, marking the first documented instance of Old World ML in the US.
- The second patient, an American ecologist with a history of cutaneous leishmaniasis in Bolivia, developed lesions in the uvula, soft palate, posterior pharynx, and larynx, attributed to Leishmania (Viannia) braziliensis.
Findings:
- The introduction of Old World Leishmania tropica into the United States represents a significant epidemiological finding.
- The case involving Leishmania (Viannia) braziliensis highlights the potential for late-onset mucosal disease years after initial cutaneous infection.
- These cases expand the known spectrum of ML presentations and geographic origins within the US.
Implications:
- These findings underscore the importance of considering diverse Leishmania species and geographic origins in ML diagnoses within non-endemic regions.
- Increased awareness and diagnostic capabilities are needed to identify both Old World and New World ML in the US.
- This emphasizes the need for robust public health surveillance for leishmaniasis in travelers and immigrants.
Related Concept Videos
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

